Vaxinz Revenue and Competitors
Estimated Revenue & Valuation
- Vaxinz's estimated annual revenue is currently $775k per year.
- Vaxinz's estimated revenue per employee is $155,000
Employee Data
- Vaxinz has 5 Employees.
- Vaxinz grew their employee count by 0% last year.
Vaxinz's People
| Name | Title | Email/Phone |
|---|
Vaxinz Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Vaxinz?
Biotechnology company focused on human infectious & neglected diseases in Africa, LatAm & Caribbean that works within a complete ecosystem to go from research to market. -Developing a diversified pipeline (that includes 6 candidates for a COVID 19 Vaccine) and agile structure streamlined to de-risk early stage development -Flexible R&D platform based on recombinant viral vector technologies, such as adenovirus, AAV, and lentivirus, capable of developing a broad set of products -Strong partner network to efficiently run preclinical and clinical trials, with years of combined tea experience working together in a diverse set of projects -One of few teams in the region that covers all the way from basic science to serving local markets
keywords:N/A
N/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Commerce
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 6 | N/A | N/A |
#2 | $0.4M | 6 | 20% | N/A |
#3 | $0.2M | 8 | -11% | $1M |
#4 | $1.1M | 8 | 0% | N/A |
#5 | $1.3M | 10 | 0% | N/A |